The Memorial Hermann Foundation is an independent non-profit organization based in Houston, Texas, established in 1969. Its primary objective is to provide financial support to the Memorial Hermann Health System, which includes a comprehensive network of 12 hospitals, affiliated physicians, and various specialty programs and services. The foundation plays a crucial role in enhancing the services offered by the Memorial Hermann Hospital System, which encompasses hospitals, inpatient rehabilitation facilities, diagnostic labs, and outpatient care centers. By supporting the health system, the foundation aims to improve healthcare access and quality for the greater Houston community, ensuring that a wide array of medical services is available to those in need. The foundation's assets are managed by a dedicated board of directors committed to advancing the mission of Memorial Hermann.
Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly during menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancer, and menstrual problems through a clinical platform that delivers personalized care protocols. These protocols are administered by clinicians who are trained in female midlife health. Midi Health enhances its services by utilizing specialized at-home labs, providing prescription medications, supplements, and lifestyle coaching. This comprehensive approach aims to empower women to manage the challenges they face during critical stages of their lives and careers.
Hippocratic AI
Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Foodsmart
Series C in 2024
Foodsmart is a digital nutrition platform focused on enhancing health outcomes through personalized dietary recommendations. The company aims to support individuals dealing with chronic diseases and food insecurity by collaborating with health plans and healthcare providers. Its online telehealth application offers real-time guidance across various settings, including homes, workplaces, grocery stores, and restaurants. This comprehensive approach enables users to make healthier food choices and select recipes that can mitigate chronic health issues, thereby promoting overall well-being. By providing access to affordable and tailored healthy eating options, Foodsmart strives to empower individuals to improve their nutrition and health.
Lone Peak
Private Equity Round in 2024
Lone Peak is a dental services organization headquartered in Denver, Colorado, that targets the underserved pediatric market segment. Established in 2003, the company specializes in providing comprehensive management services to dental practices, including those focused on orthodontics and oral surgery. Lone Peak offers a wide range of support services, such as human resources, recruiting, marketing, information technology, equipment procurement, credentialing, and payroll management. By delivering expertise in non-clinical operations, Lone Peak ensures the growth and efficiency of its clients' practices, fostering an environment conducive to high-quality dental care.
Capital Rx
Series D in 2023
Capital Rx, Inc. is a pharmacy benefit manager that specializes in managing self-insured prescription benefit plans for employers, unions, and government entities. Founded in 2017 and headquartered in New York, the company aims to transform the pricing and administration of prescriptions in the U.S. through its innovative Clearinghouse Model, which enhances transparency in the pharmacy supply chain and reduces costs for employer groups. By integrating various components of the pharmacy ecosystem into a single platform, Capital Rx improves administrative workflows, clinical oversight, and patient-provider coordination. This approach not only increases drug price visibility but also focuses on enhancing patient outcomes and healthcare efficiency, ultimately fostering better engagement between healthcare providers and patients.
AdaptX
Series B in 2023
AdaptX is a healthcare data analytics and AI company that specializes in enhancing clinical and workflow outcomes for hospitals and surgery centers. Founded in Seattle in 2016 as a spin-off from Seattle Children's Hospital, AdaptX provides a platform that enables medical leaders and clinicians to access and analyze clinical data effectively. The platform integrates algorithms with existing electronic data systems, allowing healthcare providers to monitor performance, compare treatment approaches, and define patient cohorts. Through automated analytics, AdaptX helps healthcare service providers improve the quality and safety of care while also reducing costs.
Memora Health
Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Carta Healthcare
Series B in 2023
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.
Wellvana
Venture Round in 2023
Wellvana is a healthcare company that focuses on creating a clinically integrated network platform to enhance coordination across the continuum of care. Founded in 2018 and headquartered in Nashville, Tennessee, Wellvana develops solutions that facilitate real-time decision-making and manage patient flow within the healthcare system. The company provides a high-touch approach to value-based care, allowing independent physicians and health systems to maintain their autonomy while reducing administrative burdens. This enables them to devote more time to patient care and improve health outcomes. Wellvana partners with primary care providers, specialists, and hospitals across 23 states, managing lives through various payor partnerships, including Medicare and commercial payors. The company has experienced significant growth, supporting over 1,000 physicians in assuming downside risk while promoting financial stability through innovative payment models. Wellvana's commitment to coordinated care aims to transform the patient experience and drive healthier profitability for healthcare providers.
Monogram Health
Series C in 2023
Monogram Health, Inc. is a provider of kidney care services based in Nashville, Tennessee, specializing in the management of chronic kidney disease and end-stage renal disease. Established in 2019, the company employs an innovative in-home care delivery model that integrates evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health focuses on improving patient outcomes and quality of life while reducing medical costs through predictive analysis and next-generation artificial intelligence algorithms. It collaborates with leading health plans and risk-bearing providers to deliver care across various insurance products in 34 states, aiming to enhance the management of patients with polychronic conditions and ensure seamless transitions to dialysis and pre-emptive kidney transplants.
Cedar
Series D in 2022
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and headquartered in New York, United States.
Hazel Health
Series C in 2022
Hazel Health, Inc. is a healthcare company focused on enhancing access to healthcare services for K-12 students. Founded in 2015 and based in San Francisco, the company provides a telehealth platform that allows students to consult with healthcare professionals through live video, whether they are at school or at home. By partnering with schools and school nurses, Hazel Health aims to improve the health and well-being of students, ensuring they remain healthy and prepared to learn. The platform addresses a variety of physical and behavioral health conditions, enabling doctors to prescribe over-the-counter medications at school with parental consent or call in prescriptions as needed. Hazel Health was previously known as HippoMD, Inc. before rebranding in September 2017.
EnableComp
Funding Round in 2022
EnableComp LLC is a provider of workers' compensation revenue management services, specializing in the collection of underpayments for hospitals and health systems across the United States. Established in 2000 and based in Franklin, Tennessee, the company offers a range of solutions designed to enhance the claims reimbursement process. Its key products include CompDirect, which outsources the management of workers' compensation claims; CompRecover, which reviews zero balance claims for accurate payments; and CompResolve, which addresses challenging accounts. Additionally, CompAdvocate assists in negotiating settlement offers from payers, while ContractVue analyzes and benchmarks contractual agreements. The Enforcer software further integrates with healthcare providers to optimize reimbursements from workers' compensation payers. As a subsidiary of Complete Holdings Group, EnableComp is committed to ensuring that healthcare providers maximize their revenue from services rendered to injured workers.
Clarify Health Solutions
Series D in 2022
Clarify Health Solutions, Inc. is a healthcare technology company based in San Francisco, California, that provides a software and analytics platform designed to enhance patient care delivery. The platform, known as Clarify Episode, facilitates real-time engagement among patients, clinicians, and care teams by delivering critical information and insights. It stratifies patients based on various characteristics, monitors their progress, and identifies potential complications early, prompting timely interventions. Key offerings include Care Pilot, a mobile and browser-based tool that empowers patients in their care journey; Care Connect, which enables clinicians to monitor and analyze patient data; and Care Prism, which delivers real-time business and productivity analytics for management. The company's solutions aim to improve efficiency, satisfaction, and engagement for patients, care teams, hospitals, and payers. Clarify Health Solutions was incorporated in 2015 and maintains a strategic alliance with Leidos.
Xealth
Series B in 2021
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.
Truveta
Series A in 2021
Truveta is a healthcare data platform that collaborates with physicians, life science researchers, and healthcare organizations to aggregate and analyze medical records information. By compiling data from multiple healthcare systems, Truveta de-identifies and organizes this information to provide valuable medical insights. The platform initially focused on COVID-19, aiming to expedite research efforts, enhance clinician expertise, and support families in making informed healthcare decisions. Through its innovative approach, Truveta connects treatments with outcomes and various health factors, contributing to advancements in medical research and patient care.
Gauss Surgical
Series C in 2018
Gauss Surgical, Inc. specializes in real-time blood monitoring solutions that enhance clinical decision-making in the healthcare sector. The company has developed a vision-based platform that provides accurate estimations of blood loss, facilitating timely transfusion decisions and improving patient outcomes. Its flagship product, Triton, is utilized in obstetrics to aid in the early detection of postpartum hemorrhage and offers objective metrics for assessing blood loss. Additionally, Gauss Surgical offers Triton OR, designed for operating rooms to measure blood loss from surgical sponges and suction canisters, and Triton L&D, which focuses on vaginal delivery and postpartum care. Founded in 2011, Gauss Surgical operates from its headquarters in Menlo Park, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.